Company Profile

eTect Inc
Profile last edited on: 8/25/2015      CAGE: 5YBH1      UEI: TBN2N8NDULJ3

Business Identifier: Ultra-low power wireless integrated circuits, novel combinations of sensor and self-powering circuits to deliver short-range wireless sensors and readers.
Year Founded
2009
First Award
2012
Latest Award
2015
Program Status
Inactive
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

107 Sw 140th Terrace Suite 1
Newberry, FL 32669
   (352) 378-4899
   info@etectbio.com
   www.etectbio.com
Location: Single
Congr. District: 03
County: Alachua

Public Profile

eTect is a Gainesville, Florida based company capitalizing on the opportunity to enable a new universe of connected devices through its innovative connected sensor solutions. The company has developed a patented technology platform of ultra-low power wireless integrated circuits, novel combinations of sensor and self-powering circuits and specialized materials to deliver low cost short-range wireless sensors and readers. The platform enables applications like our ID-Cap, a breakthrough wireless system that incorporates a tiny ingestible wireless sensor into capsules or pills to definitively, reliably, and safely indicate when a patient has taken their medicine.

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
15-19
Revenue Range
1.5M-2M
VC funded?
No
Public/Private
Privately Held
Stock Info
----
IP Holdings
1-4

Awards Distribution by Agency

Most Recent SBIR Projects

Year Phase Agency Total Amount
2015 2 NIH $1,154,504
Project Title: Smart Capsule for Automatic Adherence Monitoring
2012 1 NIH $149,968
Project Title: Other Functions: SBIR Phase I; 'ID-Cap System for Confirming Compliance with PHA

Key People / Management

  Neil R Euliano -- President

  Rizwan Bashirullah -- Chief Science Officer

  Eric Buffkin Jr -- President

  Shalom Darmanjian

  Glen Flores

  Brent A Myers -- Technical Lead

  Daniel Robinson -- Chief Pharmaceutical Officer

Company News

There are no news available.